Men & Women Welcome To Participate In This Cyclosporine & IC Study
If you are suffering from Interstitial Cystitis (Painful Bladder Syndrome) and have had three or more failed therapies, you may be a candidate for “Cyclosporine in Interstitial Cystitis” study at the Cleveland Clinic. Several research studies have been published showing that Cyclosporine can improve the symptoms of Interstitial Cystitis. It is a government funded study and can be found in clinicaltrials.gov
You may be eligible if you:
- Are over the age of 18 years.
- Have been diagnosed with Interstitial Cystitis.
- Have failed a minimum of three therapies.
- Active Cancer, pelvic radiation, previous urological cancer.
- Diabetes, serum Creatinine > 1.5 mg/dL, untreated proteinuria, untreated UTI, allergy to iodine, hypersensitivity to cyclosporine.
- Chronic use of opioid therapy, medication impacting cyclosporine, immunosuppressive medication.
- Pregnant or breast feeding
- Urinary diversion or bladder augmentation,
Location & Duration:
The study involves 4 – 5 visits at 1 month intervals with compensation of $50 for 4 visits. The study location is:
Glickman Urological and Kidney Institute
2050 East 96th Street
Cleveland, OH 44195
If interested and/or to learn more, please contact:
Barbara Tucky, MBA, Study Coordinator